The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor/Retinoic Acid Receptor Pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bexarotene induces the expression of ApoE in several CNS cell types and in brain extracts.
“Bexarotene has been shown to induce the expression of ApoE in several CNS cell types and in brain extracts [17,63,64]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889 · cited 1×
“RA isomers play important roles in cell proliferation, differentiation, and apoptosis (41, 42).”
BackgroundAlzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
Kanekiyo, T., Xu, H., & Bu, G. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.045 · Cited by 608
Self-citationApolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571
International Union of Pharmacology. LXIII. Retinoid X receptors
Germain, P., Chambon, P., Eichele, G., Evans, R. M., Lazar, M. A., Leid, M., De Lera, A. R., Lotan, R., Mangelsdorf, D. J., & Gronemeyer, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.7 · Cited by 496
Cholesterol homeostasis and function in neurons of the central nervous system
Pfrieger, F. W. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3018-7 · Cited by 453
Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404
Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia
Reitz, C., Tang, M.-X., Luchsinger, J., & Mayeux, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.705 · Cited by 397
Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice
Koldamova, R., Staufenbiel, M., & Lefterov, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504513200 · Cited by 350
Koldamova, R. P., Lefterov, I. M., Staufenbiel, M., Wolfe, D., Huang, S., Glorioso, J. C., Walter, M., Roth, M. G., & Lazo, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411420200 · Cited by 279
Hirsch-Reinshagen, V., Maia, L. F., Burgess, B. L., Blain, J.-F., Naus, K. E., McIsaac, S. A., Parkinson, P. F., Chan, J. Y., Tansley, G. H., Hayden, M. R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508781200 · Cited by 233
Fagan, A. M., Holtzman, D. M., Munson, G., Mathur, T., Schneider, D., Chang, L. K., Getz, G. S., Reardon, C. A., Lukens, J., Shah, J. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30001 · Cited by 222
Fitz, N. F., Cronican, A. A., Lefterov, I., & Koldamova, R. (2013) · Science · doi:10.1126/science.1235809 · Cited by 151
Veeraraghavalu, K., Zhang, C., Miller, S., Hefendehl, J. K., Rajapaksha, T. W., Ulrich, J., Jucker, M., Holtzman, D. M., Tanzi, R. E., Vassar, R., et al. (2013) · Science · doi:10.1126/science.1235505 · Cited by 133
Tesseur, I., Lo, A. C., Roberfroid, A., Dietvorst, S., Van Broeck, B., Borgers, M., Gijsen, H., Moechars, D., Mercken, M., Kemp, J., et al. (2013) · Science · doi:10.1126/science.1233937 · Cited by 128
Liraz, O., Boehm-Cagan, A., & Michaelson, D. M. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-16 · Cited by 118
ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-β1–42
Trommer, B. L., Shah, C., Yun, S. H., Gamkrelidze, G., Pasternak, E. S., Blaine Stine, W., Manelli, A., Sullivan, P., Pasternak, J. F., & LaDu, M. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.011 · Cited by 82
Flagged first, then by citations
Research works printed but not linked: 53
- Zheng, 2011, Biology and pathophysiology of the amyloid precursor protein, Mol. Neurodegener, 6, 27, 10.1186/1750-1326-6-27 · DOI
- Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Blennow, 2006, Alzheimer's disease, Lancet, 368, 387, 10.1016/S0140-6736(06)69113-7 · DOI · Paper page
- Thies, 2013, 2013 Alzheimer's disease facts and figures, Alzheimers Dement, 9, 208, 10.1016/j.jalz.2013.02.003 · DOI
- Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- Strittmatter, 1993, Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
- Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat. Rev. Neurol, 9, 106, 10.1038/nrneurol.2012.263 · DOI · Paper page
- Song, 2009, MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1, Biochem. Biophys. Res. Commun, 388, 400, 10.1016/j.bbrc.2009.08.020 · DOI
- Vance, 2010, Formation and function of apolipoprotein E-containing lipoproteins in the nervous system, Biochim. Biophys. Acta, 1801, 806, 10.1016/j.bbalip.2010.02.007 · DOI · Paper page
- Cruchaga, 2012, Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer's disease, Hum. Mol. Genet, 21, 4558, 10.1093/hmg/dds296 · DOI · Paper page
- Donkin, 2010, ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice, J. Biol. Chem, 285, 34144, 10.1074/jbc.M110.108100 · DOI · Paper page
- Fitz, 2010, Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice, J. Neurosci, 30, 6862, 10.1523/JNEUROSCI.1051-10.2010 · DOI · Paper page
- Groot, 2005, Synthetic LXR agonists increase LDL in CETP species, J. Lipid Res, 46, 2182, 10.1194/jlr.M500116-JLR200 · DOI
- Morikawa, 2005, Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-β, Neurobiol. Dis, 19, 66, 10.1016/j.nbd.2004.11.005 · DOI · Paper page
- Liu, 2007, Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1, Neuron, 56, 66, 10.1016/j.neuron.2007.08.008 · DOI · Paper page
- Weinstein, 2001, Isolation and purification of primary rodent astrocytes, Curr. Protoc. Neurosci
- Krul, 1988, Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: Importance for apolipoprotein E function, J. Lipid Res, 29, 1309, 10.1016/S0022-2275(20)38434-0 · DOI · Paper page
- Wahrle, 2007, Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms, Mol. Neurodegener, 2, 7, 10.1186/1750-1326-2-7 · DOI · Paper page
- Li, 2012, Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms, J. Biol. Chem, 287, 44593, 10.1074/jbc.M112.420224 · DOI
- Fagan, 2000, Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype, Ann. Neurol, 48, 201, 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X · DOI
- Chen, 2011, Retinoic acid isomers up-regulate ATP binding cassette A1 and G1 and cholesterol efflux in rat astrocytes: Implications for their therapeutic and teratogenic effects, J. Pharmacol. Exp. Ther, 338, 870, 10.1124/jpet.111.182196 · DOI
- Liu, 2009, Cooperative folding and ligand-binding properties of LRP6 β-propeller domains, J. Biol. Chem, 284, 15299, 10.1074/jbc.M807285200 · DOI · Paper page
- Väkevä, 2012, Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland, Acta Derm. Venereol, 92, 258, 10.2340/00015555-1359 · DOI
- Nielsen, 2010, Astrocytic Aβ 1–42 uptake is determined by Aβ-aggregation state and the presence of amyloid-associated proteins, Glia, 58, 1235, 10.1002/glia.21004 · DOI
- Idres, 2002, Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers, J. Biol. Chem, 277, 31491, 10.1074/jbc.M205016200 · DOI
- Blaner, 2001, Cellular metabolism and actions of 13-cis-retinoic acid, J. Am. Acad. Dermatol, 45, S129, 10.1067/mjd.2001.113714 · DOI
- Bastien, 2004, Nuclear retinoid receptors and the transcription of retinoid-target genes, Gene, 328, 1, 10.1016/j.gene.2003.12.005 · DOI · Paper page
- Germain, 2006, International Union of Pharmacology. LX. Retinoic acid receptors, Pharmacol. Rev, 58, 712, 10.1124/pr.58.4.4 · DOI
- Willy, 1995, LXR, a nuclear receptor that defines a distinct retinoid response pathway, Genes Dev, 9, 1033, 10.1101/gad.9.9.1033 · DOI
- Maden, 2003, Retinoic acid, a regeneration-inducing molecule, Dev. Dyn, 226, 237, 10.1002/dvdy.10222 · DOI
- Tafti, 2007, Functional implication of the vitamin A signaling pathway in the brain, Arch. Neurol, 64, 1706, 10.1001/archneur.64.12.1706 · DOI
- Cocco, 2002, Vitamin A deficiency produces spatial learning and memory impairment in rats, Neuroscience, 115, 475, 10.1016/S0306-4522(02)00423-2 · DOI · Paper page
- Shudo, 2009, Towards retinoid therapy for Alzheimer's disease, Curr. Alzheimer Res, 6, 302, 10.2174/156720509788486581 · DOI · Paper page
- Ahlemeyer, 2000, Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis, Neurochem. Int, 36, 1, 10.1016/S0197-0186(99)00101-1 · DOI
- Shen, 2009, 9-cis-Retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein, J. Neurosci. Res, 87, 545, 10.1002/jnr.21865 · DOI
- Grant, 1999, Dietary links to Alzheimer's disease: 1999 update, J. Alzheimers Dis, 1, 197, 10.3233/JAD-1999-14-501 · DOI
- Ding, 2008, Retinoic acid attenuates β-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model, J. Neurosci, 28, 11622, 10.1523/JNEUROSCI.3153-08.2008 · DOI · Paper page
- Koldamova, 2003, 22R-Hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion, J. Biol. Chem, 278, 13244, 10.1074/jbc.M300044200 · DOI · Paper page
- Walter, 2013, Cross-talk of membrane lipids and Alzheimer-related proteins, Mol. Neurodegener, 8, 34, 10.1186/1750-1326-8-34 · DOI
- Wahrle, 2004, ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE, J. Biol. Chem, 279, 40987, 10.1074/jbc.M407963200 · DOI · Paper page
- Oram, 2001, ABCA1. The gatekeeper for eliminating excess tissue cholesterol, J. Lipid Res, 42, 1173, 10.1016/S0022-2275(20)31566-2 · DOI
- Karten, 2006, Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia, J. Biol. Chem, 281, 4049, 10.1074/jbc.M508915200 · DOI · Paper page
- Wang, 2004, ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins, Proc. Natl. Acad. Sci. U.S.A, 101, 9774, 10.1073/pnas.0403506101 · DOI
- Wahrle, 2005, Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease, J. Biol. Chem, 280, 43236, 10.1074/jbc.M508780200 · DOI · Paper page
- Fan, 2009, Greasing the wheels of Aβ clearance in Alzheimer's disease: the role of lipids and apolipoprotein E, Biofactors, 35, 239, 10.1002/biof.37 · DOI · Paper page
- Koldamova, 2010, The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration, Biochim. Biophys. Acta, 1801, 824, 10.1016/j.bbalip.2010.02.010 · DOI · Paper page
- DeMattos, 2004, ApoE and clusterin cooperatively suppress Aβ levels and deposition: evidence that ApoE regulates extracellular Aβ metabolism in vivo, Neuron, 41, 193, 10.1016/S0896-6273(03)00850-X · DOI · Paper page
- Manelli, 2004, ApoE and Aβ1–42 interactions: effects of isoform and conformation on structure and function, J. Mol. Neurosci, 23, 235, 10.1385/JMN:23:3:235 · DOI · Paper page
- Stratman, 2005, Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-β peptide, Chem. Phys. Lipids, 137, 52, 10.1016/j.chemphyslip.2005.06.005 · DOI
- Verghese, 2013, ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions, Proc. Natl. Acad. Sci. U.S.A, 110, E1807, 10.1073/pnas.1220484110 · DOI · Paper page
- Wang, 2006, Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide, Mol. Cancer Ther, 5, 1060, 10.1158/1535-7163.MCT-05-0322 · DOI
- Price, 2013, Comment on “ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models”, Science, 340, 924, 10.1126/science.1234089 · DOI · Paper page
- LaClair, 2013, Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice, Mol. Neurodegener, 8, 18, 10.1186/1750-1326-8-18 · DOI · Paper page
Cited by
Sorted by citations
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Liu, C.-C., Zhao, N., Fu, Y., Wang, N., Linares, C., Tsai, C.-W., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.013 · Cited by 451
Self-citationAstrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition
Liu, C.-C., Hu, J., Zhao, N., Wang, J., Wang, N., Cirrito, J. R., Kanekiyo, T., Holtzman, D. M., & Bu, G. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3442-16.2017 · Cited by 267
Self-citationApolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation
Farmer, B., Kluemper, J., & Johnson, L. (2019) · Cells · doi:10.3390/cells8020182 · Cited by 164
APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Liu, C.-C., Murray, M. E., Li, X., Zhao, N., Wang, N., Heckman, M. G., Shue, F., Martens, Y., Li, Y., Raulin, A.-C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc9375 · Cited by 108
Self-citationKuntz, M., Candela, P., Saint-Pol, J., Lamartinière, Y., Boucau, M.-C., Sevin, E., Fenart, L., & Gosselet, F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150469 · Cited by 55
Metadata
- Authors
- Zhao, J., Fu, Y., Liu, C.-C., Shinohara, M., Nielsen, H. M., Dong, Q., Kanekiyo, T., & Bu, G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 289
- Issue
- 16
- Pages
- 11282-11292
- ISSN
- 0021-9258
- Cited by
- 67
- References
- 20
- Language
- en
- Licence
- Funders
- National Institutes of Health (R01AG046205, R01AG035355, R01AG027924, P01AG030128, P01NS074969)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
